Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.31 USD | -0.09% | +0.38% | -21.39% |
03:30pm | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
06/05 | Rocket Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.39% | 2.12B | |
+3.19% | 108B | |
+10.44% | 104B | |
+0.55% | 22.33B | |
-11.90% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-8.84% | 17.64B | |
+6.47% | 14.05B | |
+36.93% | 12.51B |
- Stock Market
- Equities
- RCKT Stock
- News Rocket Pharmaceuticals, Inc.
- Cantor Fitzgerald Initiates Rocket Pharmaceuticals With Overweight Rating, Price Target is $65